Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage; D001577:Benzophenones / Q000008:administration & dosage; D002339:Carotid Arteries; D002417:Cattle; D004176:Dipyridamole / Q000008:administration & dosage; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage; D007211:Indoles / Q000008:administration & dosage; D007213:Indomethacin / Q000008:administration & dosage; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis; D011725:Pyridines / Q000008:administration & dosage; D011799:Quinazolines / Q000008:administration & dosage; D051381:Rats; D013442:Sulfinpyrazone / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage; D013468:Suloctidil / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D001577:Benzophenones; D005343:Fibrinolytic Agents; D007093:Imidazoles; D007211:Indoles; D011453:Prostaglandins; D011725:Pyridines; D011799:Quinazolines; D013449:Sulfonamides; D013876:Thiophenes; D004176:Dipyridamole; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D001241:Aspirin; D013442:Sulfinpyrazone; D013468:Suloctidil; D007213:Indomethacin